TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) climbed 8% in premarket trading on Wednesday after the company reported major progress in its custom integration pipeline, which now totals roughly $3 million in value.
The company said it is currently working on ten active projects across its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms. These initiatives span both new and returning clients, with most activity concentrated in the life sciences industry. Several deployments are slated for completion before the end of the year, while others are moving through procurement and planning.
TOMI highlighted that its pipeline reflects high-value enterprise partnerships in regulated markets where advanced disinfection and decontamination capabilities are critical and command premium pricing. The company’s evolution into a turnkey solution provider has reshaped how medical device firms and life science manufacturers incorporate iHP technology into their operations.
“These manufacturer relationships are driving our SIS platform strategy forward,” said Elissa J. Shane, Chief Operating Officer at TOMI Environmental Solutions. “We’re offering seamless integration of iHP technology into enclosures, which is exactly what the life science market has been seeking.”
TOMI’s momentum is supported by collaborations with leading global enclosure manufacturers—including ESCO Micro Pte. Ltd., Steelco S.p.A., Pharma Biotech System Components (PBSC), Nuaire, Inc., and Getinge AB. These partnerships help position TOMI as the link between cutting-edge sterilization technologies and their practical deployment in critical environments.
The company indicated that its business development pipeline shows continued strength into 2026, underscoring its ability to maintain a steady flow of specialized projects in fields where contamination control is essential for product quality, research reliability, and patient safety.